AI Verdict
GILD has stronger fundamentals based on our AI analysis.
ELV vs GILD Fundamental Comparison
| Metric | ELV | GILD |
|---|---|---|
| Revenue | $199.1B | $29.4B |
| Net Income | $5.7B | $8.5B |
| Net Margin | 2.8% | 28.9% |
| ROE | 12.9% | 37.5% |
| ROA | 4.7% | 14.4% |
| Current Ratio | 1.54x | 1.55x |
| Debt/Equity | 0.73x | 1.10x |
| EPS | $25.21 | $6.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ELV vs GILD: Frequently Asked Questions
Is ELV or GILD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. ELV is rated BUY (75% confidence) while GILD is rated BUY (82% confidence). This is not investment advice.
How does ELV compare to GILD fundamentally?
Elevance Health, Inc. has ROE of 12.9% vs GILEAD SCIENCES, INC.'s 37.5%. Net margins are 2.8% vs 28.9% respectively.
Which stock pays higher dividends, ELV or GILD?
ELV has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ELV or GILD for long term?
For long-term investing, consider that ELV has BUY rating with 75% confidence, while GILD has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ELV vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ELV vs GILD, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.